HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of the immune response to tumors by a novel synthetic compound, (4R)-3-benzoyl-N-[(1R)-1-phenylethyl]-4-thiazolidinecarboxamide (RS-0481).

Abstract
RS-0481, (4R)-3-benzoyl-N-[(1R)-phenylethyl]-4-thiazolidinecarboxamide, is a compound that can re-establish the function of certain lymphoid cell populations impaired by the presence of a growing tumor in an animal. The compound markedly augmented the tumor-specific cytotoxic T lymphocytes, TDTH (delayed-type hypersensitivity T cells), and the nonspecific lymphokine-activated-killer-cell-like cell responses. It also enhanced the tumor-inhibitory effect of macrophages in tumor-bearing mice, but not in normal mice, indicating that it enhances the antitumor immune responses. Lymphocytes from RS-0481-treated tumor-bearing mice released significantly higher amounts of macrophage-activating factor(s) (MAF) and interleukin-2(IL-2)-like factors in culture compared with lymphocytes from untreated animals. Also, sera from treated tumor bearers showed elevated colony-stimulating factor (CSF) activity. Although the compound did not influence the factor-producing activity in mice without tumor, it enhanced the responsiveness of their bone marrow cells, T cells, and macrophages to CSF, IL-2, and MAF. It seems therefore possible that the compound enhances the responsiveness of immunocompetent cells to cytokines, resulting in a marked augmentation of antitumor T cell responses in tumor-bearing mice. Consistently it inhibited the development of lymph node metastasis of transplanted X5563 plasmacytoma, and we showed that T cells play a decisive role in this inhibition. The compound also counteracted the development of suppressor T cell activity in the spleen of tumor-bearing mice.
AuthorsS Kurakata, M Tomatsu, M Arai, H Arai, A Hishinuma, H Kohno, K Kitamura, T Kobayashi, K Nomoto
JournalCancer immunology, immunotherapy : CII (Cancer Immunol Immunother) Vol. 33 Issue 2 Pg. 71-9 ( 1991) ISSN: 0340-7004 [Print] Germany
PMID1828007 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Colony-Stimulating Factors
  • Interleukin-2
  • Thiazoles
  • Thiazolidines
  • RS 0481
Topics
  • Adjuvants, Immunologic (pharmacology)
  • Animals
  • Bone Marrow (drug effects)
  • Colony-Stimulating Factors (biosynthesis, pharmacology)
  • Female
  • Hypersensitivity, Delayed
  • Interleukin-2 (biosynthesis, pharmacology)
  • Killer Cells, Natural (drug effects)
  • Macrophage Activation (drug effects)
  • Mice
  • Mice, Inbred C3H
  • Neoplasm Metastasis
  • Neoplasms, Experimental (immunology)
  • T-Lymphocytes (drug effects)
  • T-Lymphocytes, Cytotoxic (drug effects)
  • T-Lymphocytes, Regulatory (drug effects)
  • Thiazoles (pharmacology)
  • Thiazolidines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: